Global Cell/Tissue Culture Supplies Industry - KSWO, Lawton, OK- Wichita Falls, TX: News, Weather, Sports. ABC, 24/7, Telemundo -
Member Center:
Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.
SOURCE Reportlinker
NEW YORK, March 14, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Cell/Tissue Culture Supplies Industry
http://www.reportlinker.com/p098415/Global-Cell/Tissue-Culture-Supplies-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic
This report analyzes the worldwide markets for Cell/Tissue Culture Supplies in US$ Million by the following Product Segments: Media, Sera, and Reagents. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 92 companies including many key and niche players such as Affymetrix, Inc., AMRESCO, Inc., BD Biosciences, Cell Culture Technologies, LLC, Cell Essentials, Inc., EMD Millipore, Irvine Scientific, Life Technologies Corporation, Lonza Biologics Plc, Mediatech, Inc., Millipore Corporation, Medi-Cult A/S, MP Biomedicals, PerBio Science AB, PromoCell GmbH, Sera Laboratories International, Sigma-Aldrich Corporation, SAFC Biosciences, and Vitrolife AB. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-2Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-3Cell/Tissue Culture Media, Sera and Reagents I-3Media I-3Sera I-4Reagents I-4II. EXECUTIVE SUMMARY
1. MARKET DYNAMICS II-1
Outlook II-1
Biopharmaceutical Drugs Fuel Cell Culture Market II-1
Regenerative Medicine Kindles Exciting Prospects for Cell/
Tissue Culture Supplies Market II-2
Table 1: Global Market for Tissue Engineering and
Orthopedic/Spine Cell Therapy (2010): Percentage Share
Breakdown for Stryker, DuPuy, Medtronic, Zimmer, and Others
(includes corresponding Graph/Chart) II-3
Market Scenario II-3
Industrial vs. Academic II-3
Biotechnology Sector - Affected by Collapse of Capital Market II-3
Market Structure II-4
2. TRENDS AND ISSUES II-53D Technology to Put a New Spin on In Vitro Cell Analyses II-5US Government's Policies to Boost Cell Culture Market II-5Surging Demand for Cell Culture Products II-5Stem Cells and Vaccines - Key Drivers II-6Growing Acceptance for Hi-Veg Culture Media II-6Fed-Batch Cultures - A Big Hit with Large-Scale Bioprocessors II-6Changing Trend towards Serum-Free Media II-7Proteomics and Pharmacokinetics to Drive Market Growth II-7Bioresearch and Cell Culture in Protein Based Drug Development II-8CHO, Hybridomas and Mabs Dominate Mammalian Cell Culture II-8Sluggish Fetal Bovine Serum Market II-9Specialty Media Demand on Rise II-9Emerging Alternatives to Conventional Serum Supplemented Media II-9Growth of Defined Media II-10Regulations Prompt Change in Trends II-10Media Optimization II-10Cell-Line Engineering Vs. Cell Culture Media II-10Other Trends II-10Underlying Threat to Cell Culture Industry II-11Manufacture-on-Demand: Gaining Momentum II-11Move towards Contract Manufacturing II-11Factors Impacting Growth II-11Business Models Driving the Need for Contract Manufacturing II-12Trends in Contract Manufacturing II-12Target Sectors for Contract Manufacturers II-12
3. END-USE ANALYSIS II-13
End-Use Applications II-13
Cell Therapy II-13
Growing by Leaps and Bounds II-13
Cell Therapy Applications II-14
Key Factors Affecting the Cell Therapy Market II-14
Future Trends II-14
Related Market Sectors II-14
Progenitor Cell Therapy II-14
Stem Cell Therapy II-15
Other Related Technologies II-16
Somatic Cell Nuclear Transfer (SCNT) II-16
Tissue Engineering II-16
End Use Industries II-16
4. CELL/TISSUE CULTURE: PHYSIOLOGICAL OVERVIEW II-17Introduction II-17History II-17Plant Culture: The Timeline II-17Plant Cell and Tissue Culture (PCTC) II-21Plant Tissue Culture Techniques and Applications II-22Cell/Tissue Culture Media, Sera and Reagents II-25Classical Media II-25Specialty Media II-25Serum II-25Fetal Bovine Serum II-26Serum-Free Media II-26Cell Culture Reagents II-26Role of Tissue Culture in the Growth of Cell Types II-26Equipment II-26Storage and Preservation II-27Maintenance II-27Growth Pattern II-27Harvesting II-27Suspension Cultures II-28Adherent Cultures II-28Mechanical II-28Proteolytic Enzymes II-28Standard Procedure for Detaching Adherent Cells II-28Media and Growth Requirements II-28Physiological Parameters II-28Medium Requirements (Often Empirical) II-29Feeding II-29Safety Precautions II-29Methods of Tissue Culture II-29Preparation of Media II-29Growth and Morphology II-30Sub Culturing Adherent Cells II-30Thawing Frozen Cells II-30Freezing Cells II-303D Culture-Enabling Technologies II-30Natural Scaffold Substrates II-30Hydrogels II-30Inert Non-Degradable Scaffolds II-31Biodegradable Materials II-31Cell Culture Contamination - A Looming Problem II-31Classification II-31Minor Annoyances II-32Serious Problems II-32Major Catastrophes II-32Major Cell Culture Contaminants II-32Chemical Contamination II-32Types and Sources of Potential Chemical Contaminants II-32Varied Sources of Chemical Contamination II-32Media and Components II-33Sera II-33Water II-33Storage Vessels II-34Fluorescent Lights II-34Endotoxins II-34Incubators II-34Biological Contamination II-35Varied Sources of Biological Contamination II-35Mycoplasmas II-35Levels of Cell Culture Contamination Caused by Mycoplasma II-36Airborne Particles and Aerosols II-36Cross Contamination by Other Cell Cultures II-36Consequences/Problems of Contamination II-36Controlling Cell Culture Contamination II-37Measures Aimed at Reducing Contamination Problems II-37
5. PRODUCT INNOVATIONS/INTRODUCTIONS II-38
PhoenixSongs Launches New Neural Cell Culture Media II-38
Selexis Unveils BalanCD CHO SLX A II-38
Irvine Launches BalanCD™ Cell Culture Media Product Series II-39
Thermo Fisher Launches HyCell CHO Cell-Culture Medium II-39
Corning Introduces Corning cellgro® II-40
StemCells Introduces 3 New Cell Culture Supplements II-40
SAFC® Launches New CHOZN® GS-/- Zinc Finger Nuclease-modified
Chinese Hamster Ovary Cell Line II-41
SAFC® Introduces First Product of ZFN-Modified Chinese Hamster
Ovary Cell Lines II-41
ORIGIO Unveils EmbryoGen® In Vitro Fertilization Medium II-42
6. PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST - A PERSPECTIVEBUILDER II-43Charter Medical Unveils Pharmaceutical and Biotech ProcessingBio-Pak® Cell Culture Bags II-43Vitrolife Unveils World's First Biorisk-Free Cytokines andGrowth Factors II-43Millipore Launches EpiGro Epithelial Cells and Culture Media II-43StemCells Unveils GS2-M Medium for Cell Culture II-44StemCells Introduces GS1-R™ II-44Kollodis BioSciences Introduces Cell-Culture Reagents II-44The Automation Partnership Launches Automated Cell-Culture II-44Novartis Receives Approval to Release New Vaccine II-45Invitrogen Introduces GIBCO® OpTmizer TM T-cell Expansion SFM II-45Novozymes Biopharma Rolls Out CellPrime in Partnership withMillipore II-45Invitrogen Launches Dynabeads® SSEA-4 II-46Invitrogen Rolls Out KNOCKOUT™ SR XenoFree Media II-46Lonza Develops One-Step Program II-46Millipore Unveils ESGRO Complete™ PLUS Medium II-46Millipore Introduces Hanging Millicell® Cell Culture Inserts II-46SAFC Biosciences® Launches EX-CELLTM EBx® II-47SAFC Biosciences® Rolls Out EX-Fusion and CHO Library II-47
7. RECENT INDUSTRY ACTIVITY II-48
EMD Millipore Takes Over Biochrom II-48
Kerry Ingredients & Flavours Establishes Cell Science
Laboratory at Customer Center of Excellence II-48
Merck KGaA Takes Over Beijing Skywing Technology II-48
Corning Takes Over Mediatech II-49
GE Healthcare Takes Over PAA II-49
Compass Expands Partnership with PanGen II-49
Miltenyi Enters into Partnership with TeutoCell II-50
SAFC® Enters into Licensing Deal with Agilent II-50
Life Technologies Obtains FDA Clearance to Launch StemPro® MSC
SFM II-51
Transparent Inks Agreement with Molecular Response II-51
Wockhardt Inks Agreement with Sheffield Bio-Science II-52
8. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER II-53PX'Therapeutics to Establish cGMP Production Unit II-53BioTime Asia Signs Marketing Agreement with Shanghai GenextMedical Technology II-53EHSI Acquires Synthecon's Bioreactor II-53Essential Pharmaceuticals Inks Agreement with Lifeblood Medical II-54Vitro Revises Agreement with HemoGenix II-54International Stem Cell Corporation Enters into Agreement withInsight Bioventures India to Establish ISCO India II-54GCS Inks Agreement with VWR II-55Irvine Scientific Opens New Industrial Cell Culture MediaProduction Unit in Tokyo II-56BioTime to Introduce 7 Novel Human Embryonic Progenitor CellLines and 7 New Culture Media II-56Lifeline Cell Technology Enters into Distribution Agreementwith Sristi Biosciences II-57Reinnervate Obtains Investment to Realize Commercial Viabilityof Alvetex® 3D Cell Culture Platform II-57American CryoStem Obtains Patent for 'Cell Culture Media,Kits, and Methods of Use' II-57Akron Biotechnology Merges with AppliChem II-58ChanTest Takes Over Applied Cell Sciences II-58Millipore Takes Over Guava Technologies II-58Millipore Acquires EpiTag™ Technology from Epitome Biosystems II-59MediCult's BlastAssist® Culture Media Obtains FDA Approval II-59Capsant Signs Commercialization Agreement with VistaGen II-59
9. FOCUS ON SELECT PLAYERS II-60
Affymetrix, Inc. (US) II-60
AMRESCO, Inc. (US) II-60
BD Biosciences (US) II-60
Cell Culture Technologies, LLC (Switzerland) II-61
Cell Essentials, Inc. (US) II-61
Corning, Inc. (US) II-61
EMD Millipore (US) II-62
Irvine Scientific, Inc. (US) II-62
Life Technologies Corporation (US) II-62
Lonza Biologics Plc (UK) II-63
MP Biomedicals LLC (US) II-63
ORIGIO a/s (Denmark) II-63
PromoCell GmbH (Germany) II-63
Sera Laboratories International Ltd (UK) II-64
Sigma-Aldrich Corporation (US) II-64
SAFC Biosciences, Inc. (US) II-65
Thermo Fisher Scientific, Inc. (US) II-65
Vitrolife AB (Sweden) II-65
10. GLOBAL MARKET PERSPECTIVE II-66Table 2: World Recent Past, Current & Future Analysis forCell/Tissue Culture Supplies by Geographic Region - US,Canada, Japan, Europe, Asia-Pacific (excluding Japan) andLatin American Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2010 through 2018(includes corresponding Graph/Chart) II-66
Table 3: World Historic Review for Cell/Tissue Culture
Supplies by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan) and Latin American Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) II-67
Table 4: World 15-Year Perspective for Cell/Tissue CultureSupplies by Geographic Region - Percentage Breakdown of DollarSales for US, Canada, Japan, Europe, Asia-Pacific (excludingJapan) & Latin America Markets for Years 2004, 2011 & 2018(includes corresponding Graph/Chart) II-68Cell/Tissue Culture Supplies Market by Product Segment II-69Table 5: World Recent Past, Current & Future Analysis forMedia Cell/Tissue Culture Supplies by Geographic Region - US,Canada, Japan, Europe, Asia-Pacific (excluding Japan) andLatin American Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2010 through 2018(includes corresponding Graph/Chart) II-69
Table 6: World Historic Review for Media Cell/Tissue Culture
Supplies by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan) and Latin American Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) II-70
Table 7: World 15-Year Perspective for Media Cell/ TissueCulture Supplies by Geographic Region - Percentage Breakdownof Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific(excluding Japan) & Latin America Markets for Years 2004, 2011& 2018 (includes corresponding Graph/Chart) II-71
Table 8: World Recent Past, Current & Future Analysis for Sera
Cell/Tissue Culture Supplies by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Latin American Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) II-72
Table 9: World Historic Review for Sera Cell/Tissue CultureSupplies by Geographic Region - US, Canada, Japan, Europe,Asia-Pacific (excluding Japan) and Latin American MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) II-73
Table 10: World 15-Year Perspective for Sera Cell/ Tissue
Culture Supplies by Geographic Region - Percentage Breakdown
of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan) & Latin America Markets for Years 2004, 2011 &
2018 (includes corresponding Graph/Chart) II-74
Table 11: World Recent Past, Current & Future Analysis forReagent Cell/Tissue Culture Supplies by Geographic Region -US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) andLatin American Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2010 through 2018(includes corresponding Graph/Chart) II-75
Table 12: World Historic Review for Reagent Cell/ Tissue
Culture Supplies by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan) and Latin American
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) II-76
Table 13: World 15-Year Perspective for Reagent Cell/TissueCulture Supplies by Geographic Region - Percentage Breakdownof Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific(excluding Japan) & Latin America Markets for Years 2004, 2011 &2018 (includes corresponding Graph/Chart) II-77III. MARKET
1. THE UNITED STATES III-1
A.Market Analysis III-1
Current and Future Analysis III-1
Cell & Tissue Culture Market III-1
A Brief Insight III-1
Market Trends III-2
Trend Towards Serum-Free Media III-2
Liquid and Powdered Media Account for Major Share III-2
Table 14: Leading Players in the US Cell Culture Media
Market (2010): Percentage Breakdown of Sales for
Sigma-Aldrich, Hyclone, Lonza Biologics, and Others
(includes corresponding Graph/Chart) III-2
Fetal Bovine Serum - On a Decline III-3
Rise in Cell Culture Equipment Demand Leads to Innovation III-3
Market for Stem Cell Research III-3
End-Use Analysis III-4
Table 15: US Market for Cell Culture Reagents (2010):
Percentage Breakdown by End-Use for Academic, Industrial,
and Non-Academic (includes corresponding Graph/Chart) III-4
Factors Influencing Tissue and Cell Culture Media Market III-4
Regulatory Controls III-4
Guidelines Governing Use of Cell/Tissue Culture Reagents III-5
MSDS and Hazardous Information III-5
Toxic Substances Control Act III-5
Regulatory Environment III-5
Major FDA Regulations III-6
Export/Import Stats - A Historic Perspective III-6
Table 16: US Imports of Preparation Culture Media for the
Development of Microorganisms and Plant/Human/Animal Cells
(2009): Percentage Breakdown of Import Value by Country
(includes corresponding Graph/Chart) III-6
Table 17: US Exports of Preparation Culture Media for theDevelopment of Microorganisms and Plant/Human/Animal Cells(2009): Percentage Breakdown of Export Value by Country(includes corresponding Graph/Chart) III-7Strategic Corporate Developments III-7Product Launches III-10Key Players III-13B.Market Analytics III-18Table 18: US Recent Past, Current & Future Analysis forCell/Tissue Culture Supplies by Product Segment - Media,Sera, and Reagents Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2010 through2018 (includes corresponding Graph/Chart) III-18
Table 19: US Historic Review for Cell/Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-19
Table 20: US 15-Year Perspective for Cell/ Tissue CultureSupplies by Product Segment - Percentage Breakdown of DollarSales for Media, Sera, and Reagents Markets for Years 2004,2011 & 2018 (includes corresponding Graph/Chart) III-20
2. CANADA III-21
A.Market Analysis III-21
Current and Future Analysis III-21
Biotechnology Industry III-21
B.Market Analytics III-22
Table 21: Canadian Recent Past, Current & Future Analysis
for Cell/Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-22
Table 22: Canadian Historic Review for Cell/ Tissue CultureSupplies by Product Segment - Media, Sera, and ReagentsMarkets Independently Analyzed with Annual Sales Figures inUS$ Million for Years 2004 through 2009 (includescorresponding Graph/Chart) III-23
Table 23: Canadian 15-Year Perspective for Cell/Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2004, 2011 & 2018 (includes corresponding Graph/Chart) III-24
3. JAPAN III-25A.Market Analysis III-25Current and Future Analysis III-25Strategic Corporate Development III-25B.Market Analytics III-26Table 24: Japanese Recent Past, Current & Future Analysisfor Cell/Tissue Culture Supplies by Product Segment - Media,Sera, and Reagents Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2010 through2018 (includes corresponding Graph/Chart) III-26
Table 25: Japanese Historic Review for Cell/Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-27
Table 26: Japanese 15-Year Perspective for Cell/TissueCulture Supplies by Product Segment - Percentage Breakdownof Dollar Sales for Media, Sera, and Reagents Markets forYears 2004, 2011 & 2018 (includes corresponding Graph/Chart) III-28
4. EUROPE III-29
A.Market Analysis III-29
Current and Future Analysis III-29
Market Overview III-29
B.Market Analytics III-30
Table 27: European Recent Past, Current & Future Analysis
for Cell/Tissue Culture Supplies by Geographic Region -
France, Germany, Italy, UK and Rest of Europe Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-30
Table 28: European Historic Review for Cell/Tissue CultureSupplies by Geographic Region - France, Germany, Italy, UKand Rest of Europe Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2004 through2009 (includes corresponding Graph/Chart) III-31
Table 29: European 15-Year Perspective for Cell/Tissue
Culture Supplies by Geographic Region - Percentage Breakdown
of Dollar Sales for France, Germany, Italy, UK and Rest of
Europe Markets for Years 2004, 2011 & 2018 (includes
corresponding Graph/Chart) III-32
Table 30: European Recent Past, Current & Future Analysisfor Cell/Tissue Culture Supplies by Product Segment - Media,Sera, and Reagents Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2010 through2018 (includes corresponding Graph/Chart) III-33
Table 31: European Historic Review for Cell/ Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-34
Table 32: European 15-Year Perspective for Cell/TissueCulture Supplies by Product Segment - Percentage Breakdownof Dollar Sales for Media, Sera, and Reagents Markets forYears 2004, 2011 & 2018 (includes corresponding Graph/Chart) III-35
4a. FRANCE III-36
A.Market Analysis III-36
Current and Future Analysis III-36
B.Market Analytics III-36
Table 33: French Recent Past, Current & Future Analysis for
Cell/Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-36
Table 34: French Historic Review for Cell/Tissue CultureSupplies by Product Segment - Media, Sera, and ReagentsMarkets Independently Analyzed with Annual Sales Figures inUS$ Million for Years 2004 through 2009 (includescorresponding Graph/Chart) III-37
Table 35: French 15-Year Perspective for Cell/ Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2004, 2011 & 2018 (includes corresponding Graph/Chart) III-38
4b. GERMANY III-39A.Market Analysis III-39Current and Future Analysis III-39Biotech Research Scenario III-39Table 36: German Biotech Market - A Historic Perspective(2009): Percentage Breakdown by Application Area forEnvironment, Human Health Care, Chemical industry, Food,Agriculture, Energy, and Others (includes correspondingGraph/Chart) III-40Strategic Corporate Developments III-40PromoCell GmbH - A Key Player III-41B.Market Analytics III-42Table 37: German Recent Past, Current & Future Analysis forCell/Tissue Culture Supplies by Product Segment - Media,Sera, and Reagents Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2010 through2018 (includes corresponding Graph/Chart) III-42
Table 38: German Historic Review for Cell/Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-43
Table 39: German 15-Year Perspective for Cell/Tissue CultureSupplies by Product Segment - Percentage Breakdown of DollarSales for Media, Sera, and Reagents Markets for Years 2004,2011 & 2018 (includes corresponding Graph/Chart) III-44
4c. ITALY III-45
A.Market Analysis III-45
Current and Future Analysis III-45
B.Market Analytics III-45
Table 40: Italian Recent Past, Current & Future Analysis for
Cell/Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-45
Table 41: Italian Historic Review for Cell/Tissue CultureSupplies by Product Segment - Media, Sera, and ReagentsMarkets Independently Analyzed with Annual Sales Figures inUS$ Million for Years 2004 through 2009 (includescorresponding Graph/Chart) III-46
Table 42: Italian 15-Year Perspective for Cell/ Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2004, 2011 & 2018 (includes corresponding Graph/Chart) III-47
4d. THE UNITED KINGDOM III-48A.Market Analysis III-48Current and Future Analysis III-48Biotechnology Industry - A Brief Insight III-48Regulatory Issues III-49HFE Act Guidelines III-49Ethical Issues III-49Key Players III-50B.Market Analytics III-51Table 43: UK Recent Past, Current & Future Analysis forCell/Tissue Culture Supplies by Product Segment - Media,Sera, and Reagents Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2010 through2018 (includes corresponding Graph/Chart) III-51
Table 44: UK Historic Review for Cell/Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-52
Table 45: UK 15-Year Perspective for Cell/ Tissue CultureSupplies by Product Segment - Percentage Breakdown of DollarSales for Media, Sera, and Reagents Markets for Years 2004,2011 & 2018 (includes corresponding Graph/Chart) III-53
4e. REST OF EUROPE III-54
A.Market Analysis III-54
Current and Future Analysis III-54
Scenario in other European Countries III-54
Strategic Coprorate Development III-54
Product Launches III-55
Key Players III-56
B.Market Analytics III-57
Table 46: Rest of Europe Recent Past, Current & Future
Analysis for Cell/Tissue Culture Supplies by Product Segment -
Media, Sera, and Reagents Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) III-57
Table 47: Rest of Europe Historic Review for Cell/ TissueCulture Supplies by Product Segment - Media, Sera, andReagents Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2004 through 2009 (includescorresponding Graph/Chart) III-58
Table 48: Rest of Europe 15-Year Perspective for Cell/Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera and Reagent Markets for
Years 2004, 2011 & 2018 (includes corresponding Graph/Chart) III-59
5. ASIA-PACIFIC III-60A.Market Analysis III-60Current and Future Analysis III-60Rise of Cell Culture in Asia III-60Overview of Select Markets III-60Australia III-60China III-60India III-61Cell Culture Market Constituents III-61Taiwan III-61Strategic Corporate Developments III-62B.Market Analytics III-63Table 49: Asia-Pacific Recent Past, Current & FutureAnalysis for Cell/Tissue Culture Supplies by Product Segment -Media, Sera, and Reagents Markets Independently Analyzedwith Annual Sales Figures in US$ Million for Years 2010through 2018 (includes corresponding Graph/Chart) III-63
Table 50: Asia-Pacific Historic Review for Cell/ Tissue
Culture Supplies by Product Segment - Media, Sera, and
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-64
Table 51: Asia-Pacific 15-Year Perspective for Cell/TissueCulture Supplies by Product Segment - Percentage Breakdownof Dollar Sales for Media, Sera and Reagent Markets forYears 2004, 2011 & 2018 (includes corresponding Graph/Chart) III-65
6. LATIN AMERICA III-66
A.Market Analysis III-66
Current and Future Analysis III-66
Brazilian Biotech Industry - An Overview III-66
B.Market Analytics III-67
Table 52: Latin American Recent Past, Current & Future
Analysis for Cell/Tissue Culture Supplies by Product Segment -
Media, Sera, and Reagents Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) III-67
Table 53: Latin American Historic Review for Cell/ TissueCulture Supplies by Product Segment - Media, Sera, andReagents Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2004 through 2009 (includescorresponding Graph/Chart) III-68
Table 54: Latin American 15-Year Perspective for Cell/Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera and Reagent Markets for
Years 2004, 2011 & 2018 (includes corresponding Graph/Chart) III-69
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 92 (including Divisions/Subsidiaries - 104)
The United States (58)Canada (3)Japan (3)Europe (33)- France (2)- Germany (9)- The United Kingdom (12)- Spain (1)- Rest of Europe (9)Asia-Pacific (Excluding Japan) (6)Latin America (1)
To order this report:In_Vitro_Diagnostic Industry: Global Cell/Tissue Culture Supplies Industry
Contact Clare: clare@reportlinker.com
US:(339) 368 6001
Intl:+1 339 368 6001
©2012 PR Newswire. All Rights Reserved.
 | All content © Copyright 2000 - 2013 WorldNow and KSWO. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service. |
